Skip to main content

Table 3 Initial and maximum PCT levels, morbidity and mortality according to the type of pneumonia

From: Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study

 

CAP N= 57

HAP N= 57

VAP N= 61

Overall P

P (CAP versus HAP)

P(CAP versus VAP)

Initial PCT (ng/ml)

2.4

(1.0, 15.8)

2.2

(0.4, 8.0)

0.7

(0.3, 2.15)

n.s

n.s.

< 0.001

Max. PCT (ng/ml)

5.3

(1.7, 17.7)

2.8

(0.4, 8.2)

1.0

(0.5, 3.4)

n.s.

0.021

< 0.001

Day of max. PCT

2

(1, 3)

1

(1, 2)

2

(1, 6)

< 0.001

0.012

n.s.

Maximum SOFA

9.5 ± 4.2

7.6 ± 3.8

6.7 ± 3.7

< 0.001

0.007

< 0.001

ICU length of stay (days)

13.0

(8.0, 17.5)

12.0

(7.0, 22.5)

26

(18, 43)

< 0.001

n.s.

< 0.001

28 days mortality n (%)

21 (36.8%)

6 (10.5%)

5 (8.2%)

< 0.001

0.002

< 0.001

  1. Continuous data are given as median (interquartile range) or mean ± standard deviation. CAP, community acquired pneumonia; HAP, hospital acquired pneumonia; ICU, intensive care unit; PCT, procalcitonin; n.s., not significant; SOFA, sequential organ failure assessment; VAP, ventilator associated pneumonia.
Back to article page

Critical Care

ISSN: 1364-8535